Physician profile
Sarah E Gray
NPI 1952782310
$29,940.18
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.81 · 2023: $124 · 2024: $9,689 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $4,183 · Travel and Lodging: $1,494 · Education: $34.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,212.00 |
| Food and Beverage | $4,182.87 |
| Travel and Lodging | $1,493.52 |
| Education | $34.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $19,803.95 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $8,924.84 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Regeneron Healthcare Solutions, INC. | $304.36 | 2024-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.43 | 2023-2025 | Ofev, Jascayd, Spiriva Respimat |
| Insmed, INC. | $175.41 | 2024-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $153.20 | 2024-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Inogen, INC. | $92.48 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $89.31 | 2025 | Smartvest |
| Merck Sharp & Dohme LLC | $60.25 | 2024 | Recarbrio, Zerbaxa |
| Takeda Pharmaceuticals U.S.A., INC. | $38.13 | 2025 | Glassia |
| Philips North America LLC | $24.31 | 2024 | (Ak6) Vest Therapy |
| Regeneron Pharmaceuticals, INC. | $21.51 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.